Redline Bio
    Back to catalog
    Lemon Bottle research peptide vial
    Metabolic
    99% Pure
    Popular

    Lemon Bottle

    High-concentration lipolytic solution (Riboflavin/B2, Lecithin, Bromelain, NMN) for subcutaneous adipose tissue, lipid emulsification, and localized fat-metabolism research — 10mL vial

    Select size

    $58.00/ 10mL
    ✓ View Certificate of Analysis (COA)

    For research purposes only. Not for human consumption.

    Mechanism of Action

    Lemon Bottle is a high-concentration lipolytic injectable blend containing Riboflavin (Vitamin B2), Lecithin (phosphatidylcholine), Bromelain, and NMN (Nicotinamide Mononucleotide). The formulation is studied for its synergistic effects on adipocyte membrane disruption, triglyceride emulsification, and localized fat metabolism in subcutaneous adipose tissue research models.

    How It Works

    1. 1

      Lecithin (phosphatidylcholine) emulsifies adipocyte cell membranes, releasing stored triglycerides into the interstitial space

    2. 2

      Bromelain (proteolytic enzyme from pineapple) supports breakdown of fibrous tissue and modulates local inflammatory response

    3. 3

      Riboflavin (B2) acts as a cofactor in fatty acid β-oxidation and serves as a photosensitizer enhancing the lipolytic cascade

    4. 4

      NMN supports NAD+ biosynthesis, fueling sirtuin activity and mitochondrial energy production during adipocyte turnover

    5. 5

      Combined action targets localized subcutaneous fat deposits while preserving surrounding tissue architecture

    Key Research Benefits

    • Localized adipose tissue research
    • Lipid emulsification and adipocyte membrane studies
    • Subcutaneous fat metabolism investigation
    • Combined lipolytic and NAD+ pathway exploration
    • Aesthetic and body-contouring research models
    • Adjunct to GLP-1 and lipotropic stack protocols

    Lemon Bottle has gained attention in aesthetic and metabolic research for its high-concentration, fast-acting lipolytic profile. It is widely studied alongside lipotropic blends (Lipo-C), GLP-1 agonists, and AOD-9604 to investigate combined effects on regional adiposity, lipid clearance, and adipocyte apoptosis pathways. Strictly research use only — not for human or veterinary administration.